Bristol-Myers Squibb Company

Early Clinical Lead, Oncology

Location
Princeton, NJ, US
Posted
Oct 30, 2018
Ref
R1511222
Required Education
Doctorate/PHD/MD
Position Type
Full time
Bristol-Myers Squibb is a global Biopharma company committed to a single mission: to discover, develop, and deliver innovative medicines focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis.

Join us and make a difference. We hire the best people and provide them with a work environment that places a premium on diversity, integrity, collaboration and personal development. Through a culture of inclusion, we create a better, more productive work environment. We believe that the diverse experiences and perspectives of all our employees help to drive innovation and transformative business results.

An Early Clinical Lead has the following roles:
  • Serves as a medical and scientific expert to drug discovery teams and contributes to selection of discovery compounds, development of clinical strategy and transition of compounds into early phase development.
  • Designs and develops clinical studies and research plans in support of asset strategy. Clinical studies range from first-in-human Phase I, proof of concept Phase I/II, entry registrational studies, and clinical pharmacology protocols.
  • Leads strategy development and provides advice for the translational medicine strategy for an asset as part of a multi-functional team.
  • Leads the execution of clinical studies and interpretation of data and makes appropriate recommendations based on these data.
  • Contributes to the writing, review and publishing of reports submitted to regulatory agencies
  • Builds relationships with thought leaders and principal investigators and gathers input on disease areas and design of clinical programs.
  • Contributes to continuous improvement initiatives, effective team-building and effective communication across the BMS Oncology community.


Desired Background and Experience:
  • Qualified individuals must possess an MD, MD/PhD, PhD, or Pharm D
  • Ability to plan, develop, and execute early clinical development studies including selection of relevant biomarkers and pharmacodynamic endpoints.
  • Ability to use scientific methods to test hypotheses, statistically design, analyze, interpret, and report results.
  • Ability to address Health Authority and IRB questions
  • Applicants should have strong leadership skills, yet be able to work effectively in a team environment.
  • Excellent communication skills, the ability to deliver effective presentations and strong networking abilities and creativity.
  • Ability to serve as a matrix leader or lead in a matrix environment including study teams.